Navigating the world of OAB: Lightening the load, staying on track

Industry session by ASTELLAS

  • Location:
    Room Copenhagen, North Hall (Level 1)
  • Chair:
     M. Speakman, Taunton (GB)
  • Aims and objectives of this session

    The aim of this symposium is to deliver an interactive symposium with audience dialogue throughout. The symposium will explore the factors underlying poor patient adherence to therapy in OAB and examine the importance of persistence in this area. We will share new real-world data on persistence with OAB medications and debate the benefits of a personalised approach — which treatment to use and which to avoid and why.

Chairman’s introduction – The OAB map in 2017
 M. Speakman, Taunton (GB)
Getting underway in OAB management
 F. Cruz, Porto (PT)
The perils of the doldrums
 A. Wagg, Edmonton (CA)
Staying on course
 A. Tubaro, Rome (IT)
Questions and answers